SEC Form D · filed February 16, 2021
Shoreline Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Kleanthis G. Xanthopoulos, Ph.D · La Jolla, CAExec · DirectorJustin L. Burns · Newton Centre, MADirectorChristopher S. Fuglesang · San Diego, CADirectorDavid W. Scalzo · Daytona Beach, FLDirectorMartin Jefson · Newton Centre, MADirectorThomas Bailey · HOBE SOUND, FLDirectorDan S. Kaufman · San Diego, CADirectorTrevor W. Perrott · Daytona Beach, FLDirectorSteven G. Holtzman · San Diego, CADirectorMarios G. Fotiadis · San Diego, CADirectorJohn W. Lobdell · Daytona Beach, FLDirectorAlexandra A. Clegg · Warwick, RIDirectorKleanthis G. Xanthopoulos, Ph.D · La Jolla, CAExec · DirectorJeffrey L. Ives · Newton Centre, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗